Viracta Therapeutics, Inc.
VIRXDelisted Jul 10, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001061027
Viracta Therapeutics, Inc. was delisted on Jul 10, 2025; its insiders filed their last Form 4 on Nov 27, 2024; 32 institutions reported holding it in 13F filings for Q4 2024, worth $583.0K in total; no superinvestor held it.
13F holders, Q2 2024
Institutional positions in Viracta Therapeutics, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 40
- 0 vs. Q1 2024
- Shares held
- 9.03M
- −367.4K (−3.9%) vs. Q1 2024
- Total value
- $4.91M
- −$4.67M (−48.8%) vs. Q1 2024
- New holders
- 2
- 8 more added
- Sold out
- 2
- 9 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VIRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 1 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 7 | $3.80K |
| Q4 2024 | 32 | $583.0K |
| Q3 2024 | 38 | $1.29M |
| Q2 2024 | 40 | $4.91M |
| Q1 2024 | 40 | $9.58M |
| Q4 2023 | 42 | $5.56M |
| Q3 2023 | 42 | $10.1M |
| Q2 2023 | 41 | $14.1M |
| Q1 2023 | 48 | $19.4M |
| Q4 2022 | 56 | $18.1M |
| Q3 2022 | 59 | $52.8M |
| Q2 2022 | 63 | $44.2M |
| Q1 2022 | 69 | $62.2M |
| Q4 2021 | 69 | $51.8M |
| Q3 2021 | 68 | $124.6M |
| Q2 2021 | 63 | $151.8M |
| Q1 2021 | 50 | $92.0M |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Viracta Therapeutics, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 457 | $0 | 0.00% | −1,611−77.9% | Reduced |
| Qube Research & Technologies Ltd | 2 | $1 | 0.00% | 00.0% | Unchanged |
| Private Ocean, LLC | 3 | $2 | 0.00% | +3 | New |
| Addison Advisors LLC | 4 | $3 | 0.00% | 00.0% | Unchanged |
| Parallel Advisors, LLC | 8 | $4 | 0.00% | 00.0% | Unchanged |
| GWM Advisors LLC | 14 | $8 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 171 | $93 | 0.00% | −214−55.6% | Reduced |
| Indiana Trust & Investment Management CO | 200 | $109 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 721 | $392 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 1,690 | $920 | 0.00% | +1,595+1,678.9% | Added |
| Barclays PLC | 2,668 | $1.45K | 0.00% | 00.0% | Unchanged |
| IAG Wealth Partners, LLC | 3,000 | $1.63K | 0.00% | 00.0% | Unchanged |
| RP Management, LLC | 3,700 | $2.00K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 7,337 | $3.00K | 0.00% | +2,453+50.2% | Added |
| Planning Capital Management Corp | 7,272 | $3.95K | 0.00% | 00.0% | Unchanged |
| Acadian Asset Management LLC | 10,908 | $5.00K | 0.00% | 00.0% | Unchanged |
| WealthTrust Axiom LLC | 11,396 | $6.20K | 0.00% | 00.0% | Unchanged |
| Trust Co of Toledo NA | 12,317 | $6.70K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 12,496 | $6.79K | 0.00% | +225+1.8% | Added |
| Tower Research Capital LLC (TRC) | 12,652 | $6.88K | 0.00% | +3,763+42.3% | Added |
| Hoylecohen, LLC | 14,000 | $7.61K | 0.00% | 00.0% | Unchanged |
| Beacon Pointe Advisors, LLC | 15,000 | $8.16K | 0.00% | −2,500−14.3% | Reduced |
| Inspirion Wealth Advisors, LLC | 15,000 | $8.16K | 0.00% | 00.0% | Unchanged |
| XTX Topco Ltd | 19,201 | $10.4K | 0.00% | +2,213+13.0% | Added |
| MAI Capital Management | 27,417 | $14.9K | 0.00% | −336,680−92.5% | Reduced |
| Virtu Financial LLC | 30,789 | $17.0K | 0.00% | +30,789 | New |
| Northern Trust Corp | 38,104 | $20.7K | 0.00% | −86−0.2% | Reduced |
| Ensign Peak Advisors, Inc | 61,601 | $33.5K | 0.00% | −1,805−2.8% | Reduced |
| State Street Corp | 65,867 | $35.8K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 74,000 | $40.2K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 134,544 | $73.2K | 0.00% | +16,528+14.0% | Added |
| Renaissance Technologies LLC | 217,699 | $118.4K | 0.00% | +15,200+7.5% | Added |
| Geode Capital Management, LLC | 270,773 | $147.3K | 0.00% | +18,072+7.2% | Added |
| BlackRock Inc. | 273,297 | $148.6K | 0.00% | −30,683−10.1% | Reduced |
| Aisling Capital Management LP | 288,571 | $156.9K | 0.07% | 00.0% | Unchanged |
| Laurion Capital Management LP | 407,299 | $221.4K | 0.01% | −13,127−3.1% | Reduced |
| Samsara BioCapital, LLC | 689,709 | $375.0K | 0.08% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,161,280 | $631.4K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 1,520,240 | $826.6K | 0.00% | −44,962−2.9% | Reduced |
| BVF Inc | 3,614,662 | $1.97M | 0.06% | 00.0% | Unchanged |
| United Bank | 0 | $0 | 0.00% | −25,200−100.0% | Sold out |
| NBC Securities, Inc. | 0 | $0 | 0.00% | −1,400−100.0% | Sold out |